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ABSTRACT: The work aim at investigating the channeling or modulatory effects of polyethylene glycol (PEG) 
(MW 4000 and 6000) on drug release from ibuprofen sustained release formulation. Different batches of ibuprofen 
matrix granules and tablet were prepared by melt granulation using different concentrations of carnauba wax and PEG at 
different ratios. The granule flow properties and various tablets parameters were evaluated using standard procedures. 
Drug release kinetics and mechanisms from the tablets were investigated as well as DSC and FTIR drug-excipients 
compatibility. The granules showed increasingly close packing with increase in the amounts of PEG incorporated. All 
the tablets did not meet compendial specifications with regard to crushing strength and friability. The release rate and 
extent of release were found to be influenced by the amount of PEG used as well as the carnauba wax concentration. 
PEG combination of equal amounts produced the highest release of 91 % in the formulation prepared with 12.20 %w/w 
of carnauba wax while a 1:2 combination in tablets prepared with 24.40 %w/w of carnauba wax gave a maximum drug 
release of 83 %. Drug release kinetic and mechanism were most consistent with the Higuchi model hence the release 
was diffusion mediated. DSC and FTIR studies showed no interactions between ibuprofen and the excipients. Carnauba 
wax-PEG system can be used successfully as a matrix former to sustain the release of ibuprofen for over 6 h. The studies 
indicate that the proper balance between a matrix former and a channeling agent can produce a desired drug dissolution 
profile. © JASEM 
https://dx.doi.org/10.4314/jasem.v21i5.9 
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The need to improve dosage convenience and also 
enhance patient’s compliance has led to the search for 
various ways of modifying drug release from solid 
dosage forms using polymers such as waxes, lipids 
and polyethylene glycols (PEGs). Among these 
polymers, PEG has emerged as the most favourable 
carriers because of its versatility. It is non-toxic, non-
immunogenic, non-antigenic, soluble in water and 
FDA approved (Veronese and Pasut, 2005). A variety 
of PEGs, both linear and branched, with different 
molecular weights have been exploited successfully 
as drug carriers to achieve controlled release 
(Maheshwari et al.,  2003), mask taste, (Robson, 
1999) and improve stability (Paradkar et al., 2004).  
 
Carnauba wax is a natural wax used as an ingredient 
in many pharmaceutical formulations for its 
hypoallergenic and emollient properties. Many 
carnauba wax-based lipophilic matrix tablets have 
been successfully designed to protect drugs from 
hydrolytic degradation (Avbunudiogba et al., 2013) 
and control or sustain drug release (Ahmed and 
Khalil, 2014; Arhewoh et al., 2015; Onyechi and 
Okafo, 2016). 
 
In the use of carnauba wax as a matrix former in the 
sustained release of drugs, being a solid wax, drug 
release from its porous matrix structure is controlled 
by the penetration of fluid into the porous matrix to 
dissolve the incorporated drug, followed by diffusion 
of the dissolved molecules out of the matrix. Hence, 
liquid penetration into the matrix is the rate limiting 
step in the dissolution and release of drug from the 
system. The use of agents, known as channeling 
agents or rate modifiers, capable of affecting the rate 
limiting step by modifying the processes of matrix 
liquid penetration and drug diffusion from the matrix 
is currently being explored (Uddin et al., 2009; Ibn-
Razzak et al., 2009; Ahmed and Khalil, 2014). 
Agents such as mannitol, starch, lactose, PEG 4000, 
PEG 6000, PVP K30, sodium chloride, 
microcrystalline cellulose and dicalcium phosphate 
have been successfully used as channeling agents in 
sustained release formulations (Uddin et al., 2009; 
Ibn-Razzak et al., 2009; Ahmed and Khalil, 2014; 
Bruschi, 2015). 
 
Several techniques have been employed in the 
formulation of carnauba wax matrix controlled-
release granules and tablets, which includes: melt 
coating, melt granulation, melt extrusion and direct 
compression. The application of these techniques 
depends on the physicochemical properties of the 
drug as well as the desired properties of the final 
product.  
 
Ibuprofen is a non-steroidal anti-inflammatory agent 
and it belongs to class II (High permeability low 
solubility) of the Biopharmaceutical Classification 
System (BCS). Its bioavailability is limited by its 
solvation rate. A correlation between the in vivo 
bioavailability and the in vitro solvation can be 
found. Ibuprofen is a suitable candidate for sustained 
drug release delivery system due to its short half-life 
necessitating high frequency of administration. 
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The main objective of this work is the development 
and optimization of a sustained release formulation of 
ibuprofen using carnauba wax (a hydrophobic 
polymer) as the matrix former and to evaluate the 
effects of two hydrophilic polymers (PEG 4000 and 
PEG 6000) of varying molecular weights as 
channeling agents on ibuprofen release from the 
matrix tablet. 
 
MATERIALS AND METHOD 
Materials; Ibuprofen powder and microcrystalline 
cellulose were gift samples from Edo 
Pharmaceuticals Ltd, Benin City, Nigeria. 
Polyethylene glycols (Mol.Wt 6000 and 4000) were 
purchased from Sigma-Aldrich, Germany. 
Magnesium stearate and talc (BDH Chemicals, UK), 
potassium hydrogen phosphate and sodium hydroxide 
(Merck, Germany). Carnauba wax was obtained from 
the laboratory stock in the Department of 
Pharmaceutics and Pharmaceutical Technology, 
Faculty of Pharmacy, University of Benin, Benin 
City, Edo State, Nigeria. 
 
Methods, Granulation; Using the formula in Table 1, 
melt granulation method was used in formulating 
twelve batches (A-L) of the ibuprofen granules that 
were compressed into tablets by direct compression. 
For each batch, the required quantity of carnauba wax 
sufficient to produce 100 tablets was melted in a 
stainless steel vessel over a hot water bath (> 90 °C) 
with continuous stirring. The specific amounts of 
ibuprofen and microcrystalline cellulose (MCC) were 
added to the melted wax with continuous stirring until 
a homogeneous mixture was produced. Thereafter, 
the amounts equivalent to the various ratios of PEG 
4000 and 6000 were added into the molten mass and 
stirred continuously to form a homogeneous molten 
mass that was allowed to cool at room temperature. 
The cooled mass was pressed through a sieve of 
aperture size 710 µm to give granules. The granules 
were evaluated for their flow properties and 
compressed into tablets using a single punch tableting 
machine (Manesty Machines, UK) after the geometric 
addition of the required amounts of magnesium 
stearate and talc and mixing intimately. 




A B C D E F G H I J K L 
Ibuprofen  200 200 200 200 200 200 200 200 200 200 200 200 
MCC 150 140 140 130 120 120 150 140 140 130 120 120 
Carnauba wax 50 50 50 50 50 50 100 100 100 100 100 100 
PEG 4000 - 10 - 10 10 20 - 10 - 10 10 20 
PEG 6000 - - 10 10 20 10 - - 10 10 20 10 
Magnesium stearate 5 5 5 5 5 5 5 5 5 5 5 5 
Talc 5 5 5 5 5 5 5 5 5 5 5 5 
 
Drug-excipient interaction studies; DSC and FTIR 
compatibility studies were carried out on pure 
ibuprofen powder and the formulated granules to 
investigate any interaction between the drug and the 
excipients. 
 
The DSC analysis was carried out using a Netzsch 
DSC 204F1 Phoenix apparatus (Netzsch Germany). 
Four milligrams of the sample was weighed into an 
aluminium pan and sealed. The seal was pierced and 
calibration of the calorimeter was carried out with 
indium. Heating of the sample was carried out at the 
rate of 10 °C per min from 30 to 350 °C under 
nitrogen at a flow rate of 70 ml/min. FTIR analysis of 
the sample was carried out using FTIR-4100 
Spectrophotometer (Shimadzu Co. Japan). The 
potassium bromide (KBr) tablet method was used; 
five milligrams of the sample was blended with KBr 
to 200 mg. The powder was compressed using a 
Sigma KBr press into a tablet shape. The tablet was 
placed in the sample compartment and scanned at a 




Granule evaluations, Bulk density; Ten grams 
quantity of granules was poured gently into a 100 ml 
measuring cylinder and the volume occupied by the 
sample without tapping was determined. The bulk 
density, which is the ratio of the weight of the 
granules and the volume of the granules, was 




densityBulk =      ……(1) 
 
Tapped density; The measuring cylinder containing 
the 10 g granules was tapped mechanically on a flat 
surface for about a 100 times to a constant volume 
which was recorded as the tapped volume. The 
tapped density that is the ratio of the weight of the 
granules and the tapped volume of the granules was 




densityTapped =   ... (2) 
 
Carr’s consolidation index; Carr’s index is the 
difference between the tapped and bulk density of the 
granules divided by the tapped density and the ratio 
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expressed as a percentage. The indices of the various 







= .. (3) 
 
Hausner’s ratio; The ratio of the tapped density to 
the bulk density of the granules was calculated as the 




ratiosHausner' =   …….. (4) 
 
Angle of repose; The angle of repose was measured 
according to the fixed funnel and free standing cone 
method (Richard, 1972). A funnel was clamped to the 
retort stand with its tip above a white plain paper 
placed on a flat horizontal surface. Granules 
equivalent to 10 g was carefully poured through the 
funnel while the efflux was closed and then opened 
after the granules have been poured completely. The 
granules flowed freely forming a cone. The mean 
diameters of the base of the granules cone and also 
the height of the granules were determined with the 
aid of a meter rule and the tangent of the angle of 
repose (θ) was calculated using Equation 5. 
 
r
h1tanθ −=   ……..  (5) 
Where h is the height of the heap of granules and r is 
the radius of the circular base 
 
Flow rate; The funnel method of Carstensen and 
Chan (1977) was employed. A funnel was clamped to 
the retort stand and a clean paper positioned directly 
at the base of the funnel efflux. Ten grams of the 
granule was introduced into the funnel with the efflux 
tube closed. The efflux was opened and the granules 
allowed to fall freely under gravity. The flow rate was 




rateFlow =    ……..  (6) 
 
Tablet evaluations, Weight uniformity and 
dimensions; The weight of each of 20 tablets was 
determined from each batch using an electronic 
balance while the thickness and diameter of each of 
ten tablets per batch were measured using a 
micrometre screw gauge (Gallenkamp). Their mean 
values and standard deviations were computed and 
recorded.  
 
Crushing strength; Using a motorized tablet hardness 
tester (Campbell Electronics, Model HT-30/50, 
India), the crushing strength of ten individual tablets 
per batch was determined by diametric compression. 
The mean and standard deviation values were 
calculated and recorded. 
 
Friability; Twenty tablets selected randomly from 
each batch were weighed and placed in the drum of a 
friabilator (Erweka GmbH, Germany) set to revolve 
at 25 rpm for 4 min. At the end, the tablets were 
brought out, de-dusted and re-weighed. Using 
Equation 7, the percentage loss in weight of the 








= … (7) 
 
Dissolution studies; Dissolution profiles of 6 
randomly selected tablets per batch were determined 
using the BP basket method. The dissolution 
apparatus (Caleva ST7, UK) with a basket revolution 
of 50 rpm and containing 900 ml of 0.1 N HCl 
solution thermostated at 37 ± 0.5 °C was used for the 
first 2 h and thereafter replaced with 900 ml of 
phosphate buffer pH 7.2 for the remaining 4 h. 
Aliquots of 5 ml were withdrawn at various time 
intervals dissolution fluid and replaced with an 
equivalent volume of the corresponding dissolution 
medium maintained at 37 ± 0.5 °C. The withdraw 
samples were then filtered (Whatman No. 1), diluted 
appropriately with the dissolution medium and 
analysed spectrophotometrically at wavelength of 221 
nm (T70, PG Instruments Ltd). The percentage of 
drug released at each time interval was then 
calculated from the equation (y = 0.014x + 0.097) 
obtained earlier from the ibuprofen calibration curve. 
 
Release kinetics; Data from the dissolution studies 
were fitted into various kinetic equations to determine 
the model and mechanism of ibuprofen release from 
the matrix tablets. The correlation coefficient (r2) for 
each rate order was calculated. The dissolution profile 
was considered to follow a particular rate order if the 
r
2
 value was ≥ 0.95. 
 
Zero-order: This was to determine the existence of a 
linear relationship between ibuprofen release from the  
matrix tablet and time i.e., drug release rate is 
independent of concentration. The following equation 
was used to describe the release kinetic. 
 
Q = kt   ……….  (8) 
 
Where, Q is the cumulative amount of ibuprofen 
released at time t and k is the release rate constant. A 
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graphical plot of cumulative amount of ibuprofen 
released versus time will be linear if the release obeys 
zero order release kinetics. 
 
First-order: Wagner in 1969 proposed a first order 
drug release kinetic that described a concentration 
dependent drug release rate (Wagner, 1969). The 
following equation was used to describe the release 
kinetic. 
In (1-Q) = -kt    ………..  (9) 
 
Where, Q is the cumulative amount of ibuprofen 
released at time t and k is the release rate constant. A 
graphical plot of logarithm of amount of ibuprofen 
unreleased versus time will be linear if the release 
obeys first order release kinetics. 
 
Higuchi model: This model was developed by 
Higuchi to describe the release of drug from an 
insoluble matrix as the square root of a time-
dependent process based on Fickian diffusion 
(Higuchi, 1968). It defines a linear dependence of the 
amount of drug released per unit of surface on the 
square root of time and it is expressed by the 
equation: 
 
Q = kt1/2    . . ……...  (10) 
 
Where, Q is the cumulative amount of ibuprofen 
released at time t and k is the release rate constant. A 
graphical plot of cumulative amount of ibuprofen 
released against square root of time will be linear if 
the release obeys Higuchi equation. 
 
Korsemeyer-Peppas model: Korsmeyer and co-
workers in 1983 derived an empirical equation that 
described both Fickian and non-Fickian release of 
drug from polymeric delivery systems (Korsemeyer 
et al., 1983). The logarithm of the equation can be 
representing thus; 
 
Log Q = log k + n log t      ……...  (11) 
 
Where, Q is the cumulative amount of ibuprofen 
released at time t, k is the release rate constant and n 
is the diffusional exponent determining the 
mechanism of transport of ibuprofen through the 
polymer matrix (0.45 (Fickian diffusion), 0.45 < n < 
0.89 (Anomalous non-Fickian diffusion), 0.89 (Case-
II transport) > 0.89 (Super Case-II transport)). A plot 
of the logarithm of cumulative amount of ibuprofen 
released against logarithm of time will be linear if the 
release obeys Korsemeyer-Peppas equation. 
 
Statistical analysis; The mean values of results 
obtained from the granule and tablet’s evaluations 
were subjected to student’s t-test at 5 % level of 
significance using GraphPad InStat 3.10. 
 
RESULTS AND DISCUSSION 
Flow properties of granules; Results from the 
evaluation of the granule flow properties are shown in 
Table 2. The values of the bulk and tapped densities 
of the various batches of the granules in conjunction 
with their angles of repose values showed that the 
granules had increasingly close packing with increase 
in the amounts of PEG incorporated. The angle of 
repose values ranged from 24.80 - 34.80° indicating 
granules with good to fair flow properties (Mehta and 
Barker, 1994).  
 












A 0.514 (0.011) 0.606 (0.010) 24.80 (0.21) 15.18 (0.12) 1.179 (0.014) 
B 0.496 (0.012) 0.583 (0.020) 28.20 (0.30) 14.92 (0.14) 1.175 (0.020) 
C 0.499 (0.014) 0.617 (0.011) 33.00 (0.10) 19.13 (0.82) 1.236 (0.024) 
D 0.525 (0.012) 0.612 (0.012) 34.80 (0.20) 14.20 (0.62) 1.166 (0.042) 
E 0.490 (0.022) 0.570 (0.016) 28.80 (0.15) 14.04 (0.50) 1.160 (0.030) 
F 0.490 (0.042) 0.574 (0.019) 32.30 (0.30) 14.60 (0.30) 1.171 (0.010) 
G 0.496 (0.023) 0.571 (0.022) 25.70 (0.25) 13.13 (0.27) 1.151 (0.011) 
H 0.495 (0.032) 0.581 (0.045) 26.60 (0.40) 14.80 (0.10) 1.174 (0.026) 
I 0.501 (0.010) 0.580 (0.014) 29.30 (0.12) 13.62 (0.32) 1.158 (0.031) 
J 0.513 (0.011) 0.601 (0.012) 29.80 (0.05) 14.60 (0.20) 1.171 (0.021) 
K 0.511 (0.022) 0.613 (0.010) 31.90 (0.22) 16.64 (0.16) 1.200 (0.082) 
L 0.526 (0.012) 0.614 (0.010) 27.20 (0.28) 14.33 (0.24) 1.167 (0.022) 
*Standard deviation in parenthesis 
 
Batches A and G granules containing only carnauba 
wax gave the lowest angle of repose values and they 
exhibited excellent flow properties. The 
compressibility indices and Hausner’s ratios of the 
various batches of the granules which ranged from 
13.13 - 19.13 % and 1.151 - 1.236 respectively, also 
showed the decrease in granule flowability with 
increasing concentrations of PEG. The decrease in 
granule flow with the incorporation of PEG may be 
attributable to the generation of finer granule particles 
by PEG due to incomplete mixing in the granulation 
process as a result of their different chemical nature. 
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If this was the case, the higher the amounts of PEG, 
the higher the amounts of fines produced. These finer 
particles will tend to fill void spaces in-between the 
larger sized granules leading to more cohesive 
granules with poor flow properties (Eraga et al., 
2014). 
 
Drug-excipient compatibility; DSC thermogram of 
pure ibuprofen powder (Figure 1 (a)) exhibited a 
sharp endothermic trough at 78 ºC corresponding to 
the melting point of ibuprofen and an indication of its 
purity and crystallinity while the thermogram of the 
granules (Figure 1 (b)) also showed the characteristic 
sharp endothermic trough of pure ibuprofen. This 
observation confirms the presence of ibuprofen in its 
characteristic physical and chemical form in the 
granules and rules out any possible interactions 
between ibuprofen and the excipients used in the 
formulation of the matrix tablets. 
 
All the formulated tablets in the various batches 
passed the weight uniformity test, as the variation of 
no two tablets out of the total of 20 tablets used for 
the test fell outside ± 5 % and none was outside ± 10 
% deviation from the average tablet weight (BP, 
2009). The crushing strength values of the tablets 
indicated tablets of acceptable hardness except Batch 
F tablets, as values ≥ 4 kp have been reported as 
optimal for acceptable tablet hardness (Rudnic and 
Schwartz, 2006). Batches A and G tablets containing 
only carnauba wax without PEG showed the highest 
crushing strength values of 11.75 and 12.75 kp, 
respectively, while the values of the other batches 
decreased with the incorporation of PEG and with 
increasing amounts of PEG. Also, the friability values 
of the tablets followed a reverse but similar trend as 
the tablet’s crushing strength values with the least 
values being exhibited by Batches A and G tablets 
and an increase in friability with the incorporation of 
PEG and with increasing amounts of PEG. Batches E, 
F and L tablets did not meet the official compendial 
requirement of a 0.8 - 1.0 % maximum loss of tested 
tablet weight. The decrease in tablet’s hardness and 
the inverse correlation existing here between the 
tablet’s hardness and friability may be as a result of 
the fines produced by PEG as earlier stated under 
granule properties. The filling of voids between 
particles by these finer particles might interfere with 
interparticle bond formation in the tablets leading to 
low interparticulate bridges and decreased area of 
contacts between particles and consequently 
conferring less resistance to tablet fracture and 
abrasion. Some authors have supported this indirect 
correlation between the hardness and friability of 
tablets. They have postulated that, depending on the 
fines filling these voids, they will either contribute 
towards the tablet hardness with lesser friability by 
facilitating solid interparticle bonds or lower the 
hardness with a resultant higher friability by 
weakening the particle bonds (Iwuagwu et al., 1986) 
(Oyi et al., 2009). 
 
 
Fig 1: DSC thermograms of ibuprofen powder (a) and 
the prepared tablet granules (b). 
 
The FTIR spectrum of pure ibuprofen (Figure 2 (a)) 
powder exhibited characteristic absorption bands at 
1228.58, 1422.61, 1717.58 and 2946.00 cm-1. These 
bands observed for ibuprofen remained unchanged 
when compared with the spectral data of the tablet 
granules (Figure 2 (b)). This observation ruled out the 
possibility of chemical interaction and complex 
formation between ibuprofen and the other tablet 
excipients during granulation. 
 
 
Fig 2: FTIR spectra of pure ibuprofen powder (a) and 
the prepared tablet granules (b
 
Tablet properties; Results from the post-compression evaluations of the different batches of the formulated 
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A 410 (0.03) 2.98 (0.01) 12.63 (0.02) 11.75 (0.18) 0.50 (0.03) 
B 405 (0.04) 2.96 (0.04) 12.64 (0.03) 7.63 (0.11) 0.86 (0.01) 
C 410 (0.02) 2.98 (0.03) 12.62 (0.01) 5.50 (0.18) 0.87 (0.02) 
D 408 (0.02) 2.99 (0.03) 12.63 (0.01) 5.37 (0.30) 0.95 (0.01) 
E 410 (0.03) 2.96 (0.02) 12.62 (0.03) 4.25 (0.10) 1.03 (0.04) 
F 410 (0.02) 2.97 (0.02) 12.63 (0.02) 3.80 (0.20) 1.10 (0.03) 
G 412 (0.03) 2.98 (0.04) 12.64 (0.03) 12.75 (0.17) 0.46 (0.03) 
H 412 (0.02) 2.99 (0.04) 12.63 (0.01) 7.63 (0.13) 0.73 (0.02) 
I 412 (0.03) 2.26 (0.03) 12.62 (0.03) 7.25 (0.25) 0.82 (0.02) 
J 405 (0.02) 2.98 (0.03) 12.63 (0.03) 5.00 (0.45) 0.84 (0.02) 
K 408 (0.02) 2.97 (0.03) 12.62 (0.03) 4.87 (0.21) 0.99 (0.03) 
L 408 (0.02) 2.99 (0.03) 12.64 (0.02) 4.00 (0.14) 1.04 (0.02) 
*Standard deviation in parenthesis 
 
Table 4: Correlation coefficient (R2) of the dissolution studies 
Batch 
Correlation coefficient (R2) 
Zero order First order Higuchi Korsmeyer-Peppas (n) 
A 0.7429 0.8699 0.9186 0.9389 (1.63) 
B 0.7646 0.9192 0.9347 0.9772 (1.23) 
C 0.7842 0.9171 0.9451 0.9781 (1.68) 
D 0.8958 0.9586 0.9794 0.9875 (1.67) 
E 0.8648 0.9627 0.9751 0.9940 (1.67) 
F 0.7965 0.9458 0.9505 0.9847 (1.72) 
G 0.6296 0.8524 0.8151 0.8213 (1.59) 
H 0.9030 0.9085 0.9804 0.9869 (1.64) 
I 0.7513 0.9520 0.9225 0.9682 (1.70) 
J 0.8040 0.9286 0.9285 0.9344 (1.65) 
K 0.8296 0.9454 0.9623 0.9693 (1.66) 
L 0.8100 0.9390 0.9361 0.9425 (1.67) 
 
Dissolution profile; The drug release profiles of the 
various batches of the ibuprofen matrix tablets are 
presented in Figures 3 and 4. Batches A and G tablets 
containing carnauba wax alone exhibited the highest 
ibuprofen release retardation with a maximum 
percentage drug release of 71 and 60.5 % within 6 h. 
The other batches of tablets, containing PEG showed 
variable percentage drug release in the 6 h of 
profiling with batch D tablets giving the highest drug 
release of 91%. Apart from the Batch G tablets, all 
the other tablets released over 70 % of their drug 
content within the 6 h of dissolution testing. These 
results show that with the inclusion of PEG (Mol. Wt. 
4000 and 6000) in the formulations, drug release 
increased when compared to the formulations 
containing carnauba wax alone. However, the drug 
release increased only to the extent of carnauba wax 
concentration as evident with all the batches of tablets 
containing 50 mg (12.20 %w/w) of carnauba wax 
showing percentage drug release ranging from 71 to 
91 % while those containing 100 mg (24.40 %w/w) 
of carnauba wax released a percentage range of 60.5 
to 87 %. As the concentration of carnauba wax 
increased, the drug release decreased. Also, all the 
batches formulated with PEG exhibited a percentage 
drug release of over 80 % in 6 h irrespective of the 
amount of carnauba wax indicating that PEG 
increased the release of the drug. PEG as a 
hydrophilic polymer may be acting as a channeling 
agent for the drug by increasing the porosity of the 
tablet matrix when in contact with the dissolution 
fluid and forming channels for the drug to diffuse out 
of the matrix of the tablets. However, a 1:1 
combination of PEG 4000 and 6000 produced the 
highest release of 91 % in formulation prepared with 
50 mg (12.20 %w/w) of carnauba wax (Batch D) as 
against the 1:2 combination of PEG 4000 and 6000 in 
Batch K tablets prepared with 100 mg (24.40 %w/w) 
of carnauba wax with a maximum drug release of 83 
%. In effect, the combination of the PEGs produced 
maximum modulatory release of the drug from the 
tablets, but it was influenced by the concentration of 
carnauba wax forming the matrix of the tablets. The 
results of the release mechanism and kinetics of the 
drugs from the matrix tablets are shown in Table 4 
which showed that the drug release was most 
consistent with the Korsmeyer-Peppas model since 
the correlation coefficient (r
2
) values were ≥ 0.95 and 
with the release exponent (n) > 0.89, indicates that 
drug release was Super Case-II diffusion mediated 
(Eichie et al., 2008; Eraga and Iwuagwu, 2014).   
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Fig 3: Dissolution profile of ibuprofen matrix tablets 
prepared with 12.20 %w/w (50 mg) carnauba wax (A-F) 
 
Conclusion; Sustained release matrix tablets can be 
prepared using hydrophobic carriers which act as 
very good drug retardant. PEG can be used as a 
channeling agent in waxy matrix to regulate the 
release of drug. Carnauba wax hence acts as a good 
retardant to the release of drug. With the addition of 
PEG that acted as a channeling agent, the drug release 
increased with over 80 % in 6 h.  
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